GlucoTrack, Inc., (GCTK): Price and Financial Metrics

GlucoTrack, Inc., (GCTK): $0.69

0.02 (+2.99%)

POWR Rating

Component Grades

Momentum

NR

Stability

NR

Sentiment

Quality

NR

GCTK Price/Volume Stats

Current price $0.69 52-week high $1.00
Prev. close $0.67 52-week low $0.13
Day low $0.64 Volume 81,267
Day high $0.72 Avg. volume 158,422
50-day MA $0.34 Dividend yield N/A
200-day MA $0.28 Market Cap 18.46M

GCTK Stock Price Chart Interactive Chart >


GlucoTrack, Inc., (GCTK) Company Bio


GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.


GCTK Latest News Stream


Event/Time News Detail
Loading, please wait...

GCTK Latest Social Stream


Loading social stream, please wait...

View Full GCTK Social Stream

Latest GCTK News From Around the Web

Below are the latest news stories about GLUCOTRACK INC that investors may wish to consider to help them evaluate GCTK as an investment opportunity.

GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

Rutherford, NJ, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today it has received a notification letter from Nasdaq Stock Market LLC (“Nasdaq”) that the Company has been granted an additional 180-day compliance period, or until May 20, 2024, to regain compliance with Nasdaq’s minimum bid price rule. In a notification letter

Yahoo | November 30, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start the week with a breakdown of the biggest pre-market stock movers traders need to watch on Monday morning!

William White on InvestorPlace | November 20, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off Tuesday with a breakdown of all the biggest pre-market stock movers traders need to know about this morning!

William White on InvestorPlace | November 14, 2023

GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE

Rutherford, NJ, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that Paul V. Goode, PhD, President and Chief Executive Officer has provided a shareholder update letter. To Our Valued Shareholders, As we near the end of 2023, we would like to express our gratitude for your continued support of the Company. We welcome this

Yahoo | November 13, 2023

GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Rutherford, NJ, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has achieved another milestone in its development of an implantable continuous glucose monitor (CGM) by commencing preclinical animal testing. The Company previously announced the completion and positive results of a laboratory-based feasibility study

Yahoo | October 12, 2023

Read More 'GCTK' Stories Here

GCTK Price Returns

1-mo 115.63%
3-mo 200.00%
6-mo 228.57%
1-year -11.56%
3-year -71.00%
5-year N/A
YTD 163.86%
2023 -81.45%
2022 -66.19%
2021 -9.64%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!